S
MRNA icon

Seeyond’s Moderna MRNA Stock Holding History

Seeyond’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$394K Sell
2,191
-40
-2% -$6.54K 0.04% 441
2022
Q3 		$263K Buy
2,231
+201
+10% +$30.5K 0.03% 508
2022
Q2 		$289K Buy
2,030
+223
+12% +$31.9K 0.03% 505
2022
Q1 		$311K Sell
1,807
-19
-1% -$3.2K 0.03% 517
2021
Q4 		$463K Sell
1,826
-772
-30% -$226K 0.04% 487
2021
Q3 		$999K Sell
2,598
-945
-27% -$349K 0.1% 339
2021
Q2 		$832K Sell
3,543
-731
-17% -$131K 0.08% 380
2021
Q1 		$559K Buy
4,274
+929
+28% +$135K 0.06% 435
2020
Q4 		$349K Sell
3,345
-2,250
-40% -$228K 0.04% 499
2020
Q3 		$396K Sell
5,595
-1,911
-25% -$133K 0.04% 457
2020
Q2 		$482K Buy
+7,506
New +$411K 0.05% 415

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Seeyond's MRNA Position: Q4 2022 in Review

Seeyond reduced its Moderna (MRNA) stake by 1.8% in Q4 2022, selling an estimated $6.54K and leaving 2,191 shares worth $394K. The position accounts for 0.04% of the portfolio, ranked #441.

Seeyond first reported a position in MRNA in Q2 2020 and has held it in 11 quarters since. The position peaked at $999K in Q3 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Seeyond held 2,191 shares of Moderna worth $394K as of Q4 2022.
  • Seeyond sold 40 Moderna shares in Q4 2022, an estimated $6.54K.
  • Moderna made up 0.04% of Seeyond's portfolio in Q4 2022, its #441 holding.
  • Seeyond first reported a position in Moderna in Q2 2020 and has held it in 11 quarters since.
  • Seeyond's Moderna position peaked at $999K in Q3 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.